Clinical trials for COVID-19 vaccine restarting in Monroe

Published: Nov. 9, 2020 at 9:11 PM CST
Email This Link
Share on Pinterest
Share on LinkedIn

MONROE, La. (KNOE) - The U.S has reported more than 100,000 COVID-19 cases a day for the last five days. The coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca.

Clinical Trials of America has a clinic in Monroe that recently restarted its vaccine trials. More than 60 people are now taking part in the trials which are connected to the AstraZeneca testing.

The CEO of Clinical Trials of America, Dr. Jeb Andrews, says on Monday alone doctors saw 15 people who want to take part in the trials and more are continuing to line up to join the program.

Clinical Trials of America on Armand Street is the only clinic in NELA participating in the vaccine trials. The clinic restarted its trials on October 29 after being on hold for 54 days.

The hold stemmed from an unrelated incident that had occurred overseas involving a patient who became sick after taking the vaccine.

Regulators later ruled the sickness was unrelated to the trials. The clinic has seen about 100 patients since the re-opening.

They’ve already placed 62 people in the two-year trial, and Andrews says they are doing well. He also says there’s one specific demographic he’d like to see grow.

“Were not getting the percentage we would like. We have had a good percentage of African Americans, but for our local population density, we would certainly like to have more," he said. "That’s one thing. This disease process affects everyone. It doesn’t affect only white people or black people. It affects everybody, so we want a good cross-section of people that, you know, have had the vaccine and get results from.”

The clinic has access to 1,500 doses, but enrollment is competitive. To learn more about the trials or sign up contact the clinic at (318) 267-411 or go to their website at ctamerica.net.

Copyright 2020 KNOE. All rights reserved.